REGISTERED NUMBER: SC715676 (Scotland)

Unaudited Financial Statements for the Year Ended 30 November 2025

for

Rbpharma Ltd

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

3

DIRECTOR:

Mr R Bentley

REGISTERED OFFICE:

24 Alderley Way

Cumbernauld

Lanarkshire

G68 0GU

REGISTERED NUMBER:

SC715676 (Scotland)

ACCOUNTANTS:

Greg Hannah Ltd

Chartered Accountants

26 Victoria Street

Rutherglen

Glasgow

G73 1DS

FIXED ASSETS

Tangible assets

5

365

675

CURRENT ASSETS

Debtors

6

-

1,204

Cash at bank

17,445

22,218

17,445

23,422

CREDITORS

Amounts falling due within one year

7

17,385

23,778

NET CURRENT ASSETS/(LIABILITIES)

60

(356

)

TOTAL ASSETS LESS CURRENT LIABILITIES

425

319

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

325

219

425

319

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 17 August 2026 and were signed by:

Mr R Bentley - Director

1.	STATUTORY INFORMATION

Rbpharma Ltd is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. There were no material departures from that standard.

3.	ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is derived from pharmaceutical services supplied by the company.

Turnover is measured at the fair value of the service supplied, net of discounts and is recognised at the point that the company obtains right to the consideration.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

25% on cost

Taxation

Taxation for the year comprises current tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2024 - 1 ) .

5.	TANGIBLE FIXED ASSETS

Plant and

machinery

etc

£

COST

At 1 December 2024

and 30 November 2025

1,238

DEPRECIATION

At 1 December 2024

563

Charge for year

310

At 30 November 2025

873

NET BOOK VALUE

At 30 November 2025

365

At 30 November 2024

675

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Other debtors

-

1,204

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Taxation and social security

12,496

13,601

Other creditors

4,889

10,177

17,385

23,778

8.	RELATED PARTY DISCLOSURES

At the 30th November 2025, the company owed Mr R Bentley (Director) £4,889 (2024 £10,177). Miss K Morris (Shareholder) owed the company £NIL (2024 £1,204).

These above loans are interest free and have no fixed repayment terms.